Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Expired OTCs, formula cost Walmart $775,000 in N.J.

This article was originally published in The Tan Sheet

Executive Summary

Walmart agrees to pay $775,000 and revise its practices to comply with New Jersey laws after a judge finds the firm sold expired infant formula and nonprescription drugs. The state court ruling found the N.J. Office of the Attorney General proved four of the eight counts in a 2008 lawsuit, including that Walmart sold items at incorrect prices, the AG said Oct. 19. The remaining counts, for questionable business practices and other violations, are to be decided in a trial in Hudson County. Under the settlement, the firm will pay $500,000 in penalties, reimburse the state $160,000 for legal expenses and $40,000 for investigative costs, and pay $75,000 for a consumer education initiative. The settlement requires Walmart to periodically inspect OTC drugs and infant formula and monitor merchandise price accuracy at New Jersey stores. Walmart admitted no wrongdoing in the settlement that supersedes a 2004 consent order the firm and state made to resolve similar issues

You may also be interested in...



J&J To Power Ahead With 10 Launches In Four Years

 Johnson & Johnson has achieved exceptional growth in recent years, and a raft of new products is set to sustain it further. 

Bayer's Efforts To Pioneer Tumor-Agnostic Market In Europe Held Back

Bayer’s drive to lead a new market opportunity in Europe for histology-independent cancer agents like Vitrakvi has been set back by interim decisions from the UK’s NICE and Germany’s IQWiG, but there is a now a clear pathway to follow.

 

Countries Urged To Open Up On Managed Entry Deals

Performance-based managed entry agreements need to be made more effective, but this can only happen if countries relax their stance on confidentiality and share information on MEAs amongst themselves, says a working paper from the OECD.

Topics

UsernamePublicRestriction

Register

PS104621

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel